ุฃูู ุดูุก ุงูุฏูุชูุฑุฉ ูุงูุช ุงู ุงูุฌุฒุฆูุฉ ูุฏู ู
ุชูุฏู
ุฉ ูุงุฌุฏ ุจุงููุณุจุฉ ูุซุงูุซุฉ ููุงุฎุฏูุง ุนููู ููุงุท ู
ุนููุฉ ูุฑูุฒูุง ุนูููุง~
Audio
AudioLab
ูุฏู ุจุฏุงูุฉ ุชุณุฌูู ุงูู
ุญุงุถุฑุฉ ูุงูุช ุดู ุงูู
ูู
ู ุดุฑุญุช ุจุงุซููุณููููุฌู ุจูุด ูููู
ูุง ุงู drugs
ุงููู ูุงูุช ุนูููู ูุฌู ุดูุฑุช ููุช
1 list vaughan william classification
2 adverse effects of class I a
3 adverse effects of Amiodarone
4 precautions should be done to pt taking Amiodarone
1 list vaughan william classification
2 adverse effects of class I a
3 adverse effects of Amiodarone
4 precautions should be done to pt taking Amiodarone
โค1๐1
ููุงุท ู
ูู
ุฉ mcq ๐ด
โซ๏ธevery anti arrhythmic drugs have pro arrhytmogenic actions
โซ๏ธprocainamide has moderate dissociation rate - moderate conduction block + ganglion blockade
โซ๏ธdrugs inhibit action of quinidine: (digoxin - beta bl. - verapamil) โAVN
โซ๏ธclass I a used on broad sprectum
โซ๏ธclass I b on ventricular arrhythmias
โซ๏ธclass I c on SV arrhythmias
โซ๏ธclass III (Amiadarone) broad spectrum (terminate PSVT)
โซ๏ธclass IV (verapamil) SV arrhythmias (2nd choice if PSVT with asthma)
โซ๏ธlidocaine blocks inactivated Na channels in ischemic tissue
โญโซ๏ธlidocaine best used after MI or cardiac surgery
โซ๏ธ(case) pt developed arrhythmia after cardiac surgery which drug of choice?
lidocaine
โซ๏ธclass 1b (lidocaine) not used orally and can cause convulsions
โซ๏ธclass Ic marked (AVN) conduction block
โซ๏ธclass 1c (propafenone) CI in bronchospasm
โญโซ๏ธAmiodarone (ู ูู ุฉ ูููุง) K channel bl
โญโซ๏ธ(case) use beta bl. in exercise - thyrotoxicosis - pheochromocytoma
โซ๏ธAdenosine used in emergency - PSVT (drug of choice)
CI in asthma (case)
โซ๏ธ(case) verapamil drug of choice in prophylaxis PSVT
โซ๏ธ(case) beta bl. drug of choice in SV arrhythmia after MI
โซ๏ธ(case) lidocaine drug of choice in ventricular arrhythmia from MI or from digitalis toxicity
โซ๏ธcinchonism is adverse affects of quinidine (tinnitus - loss of hearing - blurred vision)
โซ๏ธevery anti arrhythmic drugs have pro arrhytmogenic actions
โซ๏ธprocainamide has moderate dissociation rate - moderate conduction block + ganglion blockade
โซ๏ธdrugs inhibit action of quinidine: (digoxin - beta bl. - verapamil) โAVN
โซ๏ธclass I a used on broad sprectum
โซ๏ธclass I b on ventricular arrhythmias
โซ๏ธclass I c on SV arrhythmias
โซ๏ธclass III (Amiadarone) broad spectrum (terminate PSVT)
โซ๏ธclass IV (verapamil) SV arrhythmias (2nd choice if PSVT with asthma)
โซ๏ธlidocaine blocks inactivated Na channels in ischemic tissue
โญโซ๏ธlidocaine best used after MI or cardiac surgery
โซ๏ธ(case) pt developed arrhythmia after cardiac surgery which drug of choice?
lidocaine
โซ๏ธclass 1b (lidocaine) not used orally and can cause convulsions
โซ๏ธclass Ic marked (AVN) conduction block
โซ๏ธclass 1c (propafenone) CI in bronchospasm
โญโซ๏ธAmiodarone (ู ูู ุฉ ูููุง) K channel bl
โญโซ๏ธ(case) use beta bl. in exercise - thyrotoxicosis - pheochromocytoma
โซ๏ธAdenosine used in emergency - PSVT (drug of choice)
CI in asthma (case)
โซ๏ธ(case) verapamil drug of choice in prophylaxis PSVT
โซ๏ธ(case) beta bl. drug of choice in SV arrhythmia after MI
โซ๏ธ(case) lidocaine drug of choice in ventricular arrhythmia from MI or from digitalis toxicity
โซ๏ธcinchonism is adverse affects of quinidine (tinnitus - loss of hearing - blurred vision)
๐2๐ฅฐ1
ุงู ุดุงุก ุงููู ูู
ูุช ุฌุฒุฆูุฉ ุงูุณู ูู ุงุณ ู ูู ุงูููุงุท ุงูู
ูู
ุฉ ุชุณุงุนุฏูู
ูู ุงูุชุงุชูุฑูุงู ู ุงููุงููู ู ุฑุจู ูููููุง~ ๐๐ป
โค10๐ฅฐ1
ุงู
ุณููููุงุช ุฏ. ู
ุญู
ุฏ ุงูุนู
ุงู
ู
โค6
ูุชุจุช ู
ุฌู
ูุนุฉ ุดูุฑุช ููุช ุงููู ุงุญุชู
ุงู ูุฌู ูู ุงููุงุฑู
ุง ูุฒููู ุชูุงุ
Anonymous Poll
57%
ุงูุง
43%
ูุฒูู ุจุนุฏ ุงูู
ุนู
ู
ูุฑุฑุช ุฃู ุฃูุถู ูุฒููู ุจุนุฏ ุงูู
ุนู
ู ูุฃู ุฏูุชูุฑุฉ ุฎุฏูุฌุฉ ุงุญุชู
ุงู ุชูุฒู ูููุณ ุนูู ุชูุงุตูู ุงูุฅู
ุชุญุงู ู ู
ู
ูู ุชููู ุนูู ุดู ูุฑูุฒูุง ูู ุงูุดูุฑุช~ ๐ค
โค20๐5
SN (cvs cns endo blood) .pdf
361.7 KB
โค20๐1
ุชุฌู
ูุนุฉ ุดูุฑุช ููุช ููููุฑุณุงุช ุงููุจุงุฑ (cvs - cns - endo - blood)
ูู ููุงุท ุณู ุนุชูุง ู ู ุชุณุฌููุงุช ุงูุฌุงู ุนุฉ ู ุงุถุงูุงุช ู ูู~ ๐๐ป
ูู ูู ุงุณุชูุณุงุฑ ุฃู ุชุนุฑููุง ุณุคุงู ู ูู ู ุถูุชุด ุฏุฒููู
@kukxu0
ูู ููุงุท ุณู ุนุชูุง ู ู ุชุณุฌููุงุช ุงูุฌุงู ุนุฉ ู ุงุถุงูุงุช ู ูู~ ๐๐ป
ูู ูู ุงุณุชูุณุงุฑ ุฃู ุชุนุฑููุง ุณุคุงู ู ูู ู ุถูุชุด ุฏุฒููู
@kukxu0
โค28๐1
Forwarded from Deleted Account
CamScanner 08-05-2022 19.07.pdf
7.2 MB
ุชุฑููุฒุงุช ุงู ุฌุงู
ุนู ูู ู
ููุฌ ูุจู ุงูุฌุฒุฆู
ุงูุญู
ุฏ ููู ู
ูุด ุดูุฑุช ููุช ูุจู ุงูุฌุฒุฆู ุจุณ ููุง ุณุงุนุงุช ููุช ูุฌูุฒ ููู ู ุฌูุช ุจูุฒูู ุชูุง ๐๐
ุงู ุดุงุก ุงููู ุญูุฒู ุจุงูู ุดูุฑุช ููุช ู ุงูุฅูุณุจูุงูู ุงููู ุจุนุฏ ุงูุฌุฒุฆู ุงูููู ุฃู ุจูุฑุฉ ๐ค
ุทูุจ ูู ูู ุญุฏ ูุงุชุจ ุงูุฅูุณุจูุงูู ูุจู ุงูุฌุฒุฆู ูุฏุฒูุง ุจูุด ูุฒููุง ู ูุณุชููุฏูุง ูููุง ููุฃุณู ุญุตูุชุด ูุฑุตุฉ ููู ูู ๐๐ป
@kukxu0
ุงู ุดุงุก ุงููู ุญูุฒู ุจุงูู ุดูุฑุช ููุช ู ุงูุฅูุณุจูุงูู ุงููู ุจุนุฏ ุงูุฌุฒุฆู ุงูููู ุฃู ุจูุฑุฉ ๐ค
ุทูุจ ูู ูู ุญุฏ ูุงุชุจ ุงูุฅูุณุจูุงูู ูุจู ุงูุฌุฒุฆู ูุฏุฒูุง ุจูุด ูุฒููุง ู ูุณุชููุฏูุง ูููุง ููุฃุณู ุญุตูุชุด ูุฑุตุฉ ููู ูู ๐๐ป
@kukxu0
โค31๐1
BRONCHIAL ASTHMA (SN)
โwrite MOA of SABA?
stimulate beta 2 receptors:
1. bronchodilation
2. inhibition of mast cell and cytokines
3. increase bronchial mucociliary clearance
โlist adverse effects of selective beta 2 agonists?
1. tremors - anxiety
2. tachycardia
3. tolerance
4. hypokalemia and ms. cramps
โwhat are indications of ipratopium?
1. asthma induced by psychogenic or beta stim.
2. asthmatic pt. intolerant to tachycardia or anxiety of beta 2 agonists or theophylline (cardiac - thyrotoxicosis - elderly)
3. acute severe asthma (adjuvant)
4. COPD
โmention disadvantages of ipratopium?
1. tolerance > blocks presynaptic M2 receptord > ACh release
2. delayed onset less effective than beta 2
โwrite MOA of methylxanthines?
1. inhibit phosphodiesterase > increase CAMP
a. direct BD
b. anti inf. decrease cytokines and mast cell mediators - inhibit late asthmatic response
2. block adenosine receptors
โlist adverse effects of theophylline?
1. headache - insomnia - anxiety
2. tachy - arrhythmia
3. peptic ulcer
4. narrow safety margin (monitor serum lvl)
โmention indications of theophylline?
1. bronchial asthma 2nd choice
a. short term relief of acute bronchospam
b. long term control (nocturnal asthma)
c. acute severe asthma
2. COPD
3. neonatal apnea
โwrite MOA of corticosteroids in bronchial asthma?
1. PLA2 > decrease LT PGs > decrease inf.
2. VC > decongestant
3. increase number of beta 2 > indirect BD (potentiate beta 2 agonist)
โwrite MOA of SABA?
stimulate beta 2 receptors:
1. bronchodilation
2. inhibition of mast cell and cytokines
3. increase bronchial mucociliary clearance
โlist adverse effects of selective beta 2 agonists?
1. tremors - anxiety
2. tachycardia
3. tolerance
4. hypokalemia and ms. cramps
โwhat are indications of ipratopium?
1. asthma induced by psychogenic or beta stim.
2. asthmatic pt. intolerant to tachycardia or anxiety of beta 2 agonists or theophylline (cardiac - thyrotoxicosis - elderly)
3. acute severe asthma (adjuvant)
4. COPD
โmention disadvantages of ipratopium?
1. tolerance > blocks presynaptic M2 receptord > ACh release
2. delayed onset less effective than beta 2
โwrite MOA of methylxanthines?
1. inhibit phosphodiesterase > increase CAMP
a. direct BD
b. anti inf. decrease cytokines and mast cell mediators - inhibit late asthmatic response
2. block adenosine receptors
โlist adverse effects of theophylline?
1. headache - insomnia - anxiety
2. tachy - arrhythmia
3. peptic ulcer
4. narrow safety margin (monitor serum lvl)
โmention indications of theophylline?
1. bronchial asthma 2nd choice
a. short term relief of acute bronchospam
b. long term control (nocturnal asthma)
c. acute severe asthma
2. COPD
3. neonatal apnea
โwrite MOA of corticosteroids in bronchial asthma?
1. PLA2 > decrease LT PGs > decrease inf.
2. VC > decongestant
3. increase number of beta 2 > indirect BD (potentiate beta 2 agonist)
โค6๐4
This media is not supported in your browser
VIEW IN TELEGRAM
GIT (SN)
โclassify peptic ulcer drugs?
1. drugs that inhibit gastric acid secretion
2. drugs that neutrilize gastric acid
3. mucosal protective drugs
4. anti H.pylori drugs
โlist drugs that inhibit gastric acid secretion?
1. H2 receptor antagonists (cimetidine - ranitidine - famotidine)
2. proton pump inhibitor (omeprazole)
3. anticholinergic drugs (pirenzipine - telenzipine)
4. prostaglandin analogues (misoprostol)
โwrite MOA of H2 antagonists?
1. competitive inhibitor suppress basal and meal stimulated acid secretion in a linear dose dependant manner
2. reduce secretion stimulated by histamine as well as by gastrin and cholinomimetic agents
โwhat are A/E of H2 blockers?
1. headache diarrhea constipation
2. tolerance (rebound hyperacidity)
3. sedation - hallucination (cimetidine)
4. antiandrogenic (cimetidine): gymecomastia - impotence - mestrual problems - galactorrhea
5. enzyme inhibition (cimetidine)
6. hypotension - brady (if give IV)
โwrite MOA of proton pump inhibitors?
1. are lipophilic weak bases (PH 4-5)
2. after int. absorption diffuse into acidified compartments (parietal cell)
3. becomes protonated (active form)
4. forms a covalent disulfide bond with H/K ATPase
5. irreversibly inactivates enzymes
โwrite MOA of sucralfate?
1. in acidic environment PH<4 it polymerizes by cross linking molecule to form sticky viscous gel that adhere ulcer
2. act as physical barrier
3. stim. PG and HCO3
4. bind to epithelial - fibroblast growth factor
โlist adverse effects of sucralfate?
1. nausea - vomiting - dry mouth
2. flatulence - constipation
3. AL toxicity: osteomalacia - encephalopathy
* triple therapy: omeprazole - clarithromycin - amoxicillin (14 days)
โlist advantages of famotidine and ranitidine over cimetidine?*
FAMOTIDINE:
1. most potent
2. 50% decomposed by acid
3. 50% bioavailability
4. excreted mainly by kidney
5. no enzyme inhibiting
RANITIDINE
1. more potent -less enzyme inhibiting
2. anti H.pylori
3. 50% bioavailability
4. 50% metabolized in liver
โdiscuss advantage of PPI over H2 antagonists?*
1. higher efficacy better relief
2. more prolonged effect
3. more effect in H.pylori
โmention uses of anti secretory drugs?*
1. PU 2. anti H.pylori 3. GERD
4. zollinger ellison syndrome
5. stress ulcer
6. acute gastritis
7. bleeding esophageal varices
โexplain antacid drug interaction?*
1. change gastric urinary PH
2. delay gastric emptying
3. chelation: Al salts form insoluble complexes with other drugs
โdifferentiate b/w 2 types of antacid?*
LOCAL ANTACID
โขAl hydroxide > constipation
โขMg salts > diarrhea
โขCa carbonate:
1. constipation
2. rebound hyperacidity
3. milk alkali syndrome
4. increase CO2 flatulence
SYSTEMIC ANTACIDS
โขNaHCO3 > rapid onset potent
1. systemic alkalosis
2. rebound hyperacidity
3. Na dangerous in HF HTN renal ds.
4. increase CO2 flatulence
5. alkaline urine - renal stones
โclassify peptic ulcer drugs?
1. drugs that inhibit gastric acid secretion
2. drugs that neutrilize gastric acid
3. mucosal protective drugs
4. anti H.pylori drugs
โlist drugs that inhibit gastric acid secretion?
1. H2 receptor antagonists (cimetidine - ranitidine - famotidine)
2. proton pump inhibitor (omeprazole)
3. anticholinergic drugs (pirenzipine - telenzipine)
4. prostaglandin analogues (misoprostol)
โwrite MOA of H2 antagonists?
1. competitive inhibitor suppress basal and meal stimulated acid secretion in a linear dose dependant manner
2. reduce secretion stimulated by histamine as well as by gastrin and cholinomimetic agents
โwhat are A/E of H2 blockers?
1. headache diarrhea constipation
2. tolerance (rebound hyperacidity)
3. sedation - hallucination (cimetidine)
4. antiandrogenic (cimetidine): gymecomastia - impotence - mestrual problems - galactorrhea
5. enzyme inhibition (cimetidine)
6. hypotension - brady (if give IV)
โwrite MOA of proton pump inhibitors?
1. are lipophilic weak bases (PH 4-5)
2. after int. absorption diffuse into acidified compartments (parietal cell)
3. becomes protonated (active form)
4. forms a covalent disulfide bond with H/K ATPase
5. irreversibly inactivates enzymes
โwrite MOA of sucralfate?
1. in acidic environment PH<4 it polymerizes by cross linking molecule to form sticky viscous gel that adhere ulcer
2. act as physical barrier
3. stim. PG and HCO3
4. bind to epithelial - fibroblast growth factor
โlist adverse effects of sucralfate?
1. nausea - vomiting - dry mouth
2. flatulence - constipation
3. AL toxicity: osteomalacia - encephalopathy
* triple therapy: omeprazole - clarithromycin - amoxicillin (14 days)
โlist advantages of famotidine and ranitidine over cimetidine?*
FAMOTIDINE:
1. most potent
2. 50% decomposed by acid
3. 50% bioavailability
4. excreted mainly by kidney
5. no enzyme inhibiting
RANITIDINE
1. more potent -less enzyme inhibiting
2. anti H.pylori
3. 50% bioavailability
4. 50% metabolized in liver
โdiscuss advantage of PPI over H2 antagonists?*
1. higher efficacy better relief
2. more prolonged effect
3. more effect in H.pylori
โmention uses of anti secretory drugs?*
1. PU 2. anti H.pylori 3. GERD
4. zollinger ellison syndrome
5. stress ulcer
6. acute gastritis
7. bleeding esophageal varices
โexplain antacid drug interaction?*
1. change gastric urinary PH
2. delay gastric emptying
3. chelation: Al salts form insoluble complexes with other drugs
โdifferentiate b/w 2 types of antacid?*
LOCAL ANTACID
โขAl hydroxide > constipation
โขMg salts > diarrhea
โขCa carbonate:
1. constipation
2. rebound hyperacidity
3. milk alkali syndrome
4. increase CO2 flatulence
SYSTEMIC ANTACIDS
โขNaHCO3 > rapid onset potent
1. systemic alkalosis
2. rebound hyperacidity
3. Na dangerous in HF HTN renal ds.
4. increase CO2 flatulence
5. alkaline urine - renal stones
โค7๐5
๐๐ฃ๐ ๐ช๐๐๐ฃ ๐๐ ๐ฅ๐๐ค ~๐ pinned ยซุชุฌู
ูุนุฉ ุดูุฑุช ููุช ููููุฑุณุงุช ุงููุจุงุฑ (cvs - cns - endo - blood) ูู ููุงุท ุณู
ุนุชูุง ู
ู ุชุณุฌููุงุช ุงูุฌุงู
ุนุฉ ู ุงุถุงูุงุช ู
ูู~ ๐๐ป ูู ูู ุงุณุชูุณุงุฑ ุฃู ุชุนุฑููุง ุณุคุงู ู
ูู
ู
ุถูุชุด ุฏุฒููู @kukxu0ยป